![]() SIVA Therapeutics Siva Therapeutics is a company aimed to develop interventional oncology treatments. | Simphotek Simphotek is a biotechnology company developing medical devices for light-based cancer treatments. | ![]() AroCell AroCell AB is an in vitro diagnostics company focusing on the monitoring of hematological malignancies, breast cancer, and other solid tumors. | |||
Founding Date | Founding Date 2014 | Founding Date 2010 | Founding Date 2007 | Founding Date 2003 | Founding Date 2005 |
Type | Type Private | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations West Hollywood, US HQ | Locations Austin, US HQ | Locations Newark, US HQ | Locations Uppsala, SE HQ | Locations Isfiya, IL HQ New York, US |
Employees | Employees 7 | Employees 3 | Employees 5 | Employees 20 | Employees 85 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 11 m | Valuation ($) 7 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) kr53.1m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods kr21.8m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit kr31.4m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income (kr12.2m) (FY, 2025) | Net income $4.1m (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 56.1k | Total funding raised $ 39.3m |

Siva Therapeutics is a company aimed to develop interventional oncology treatments.
View companySimphotek is a biotechnology company developing medical devices for light-based cancer treatments.
View company
AroCell AB is an in vitro diagnostics company focusing on the monitoring of hematological malignancies, breast cancer, and other solid tumors.
View company